James V. Dunne

Tocilizumab in systemic sclerosis: a randomised, double-blind, placebo-controlled, phase 3 trial

Dinesh Khanna, Celia J. F. Lin, Daniel E. Furst et al. · The Lancet Respiratory Medicine · 2020 · 612 citations · Full text

Autoimmune Disease, Systemic Scleroderma, Immunology +3

Regulatory T cells produce profibrotic cytokines in the skin of patients with systemic sclerosis

Katherine G. MacDonald, Nicholas A.J. Dawson, Qing Huang et al. · Journal of Allergy and Clinical Immunology · 2015 · 153 citations

Inflammation, Autoimmune Disease, Scleroderma +15

Does Systemic Sclerosis–Associated Interstitial Lung Disease Burn Out? Specific Phenotypes of Disease Progression

Sabina A. Guler, Tiffany A. Winstone, Darra Murphy et al. · Annals of the American Thoracic Society · 2018 · 103 citations

Improving the sensitivity of the American College of Rheumatology classification criteria for systemic sclerosis.

Marie Hudson, Suzanne Taillefer, Russell W. Steele et al. · PubMed · 2008 · 82 citations

The Scleroderma Patient-Centered Intervention Network Cohort: baseline clinical features and comparison with other large scleroderma cohorts

Dane H Dougherty, Linda Kwakkenbos, Marie‐Eve Carrier et al. · Lara D. Veeken · 2018 · 79 citations · Full text